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Background: Quadripolar left ventricular (LV) leads are capable of pacing from four different electrodes
which allows for easier and more stable intra-operative lead positioning with optimal pacing parameters.
We therefore investigated the rate of combined intra-operative and post-operative LV lead related events
in quadripolar vs. bipolar LV lead cardiac resynchronization therapy (CRT) recipients in the real world
setting.
Methods: We retrospectively collected data for N ¼ 1441 patients at our institution implanted with
quadripolar (n ¼ 292) or bipolar (n ¼ 1149) LV leads from 2012 to 2014 and followed them to the primary
end-point of composite lead outcome deﬁned as intra-operative lead implant failure or post-operative
lead dislodgement or deactivations.
Results: Patients implanted with a quadripolar lead were younger (70.6 ± 11.4 vs 72.5 ± 11.6, p ¼ 0.014)
and had higher incidence of diabetes (41.8% vs 32.8%, p ¼ 0.004) compared to those with bipolar leads.
All other baseline characteristics were comparable. Patients implanted with a quadripolar were signif-
icantly less likely to reach the primary endpoint in the ﬁrst 12 months after LV lead implantation (Hazard
Ratio 0.22, 95% Conﬁdence Interval 0.08e0.60, p ¼ 0.001). There were no differences between the two
groups in rates of hospitalization for any cause or in mortality.
Conclusion: In this real world study, quadripolar LV leads have signiﬁcantly lower rates of implantation
failure and post-operative lead dislodgement or deactivation. These results have important clinical im-
plications to CRT recipients.
Copyright © 2016, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Congestive heart failure is a leading cause of morbidity and
mortality with a 20%e30% death rate at 3 years [1,2,3]. Cardiac
resynchronization therapy (CRT) is an effective adjunctive therapy
for many heart failure patients [4,5]. CRT is achieved by pacing both
the right (RV) and left (LV) ventricles with the LV lead usually
placed in a branch of the coronary sinus through a transvenous
approach [6]. Anatomical challenges occasionally result in failure of
LV lead placement during the procedure or in lead dislodgement in
the post-operative period, necessitating reoperation for reposi-
tioning [7,8,9]. The major reasons for reoperation are LV leadC Presbyterian, Suite B 535,
Rhythm Society.
ociety. Production and hosting by
l., Lead related complications
oi.org/10.1016/j.ipej.2016.10.dislodgement with loss of capture, phrenic nerve stimulation (PNS),
and increased LV pacing thresholds without obvious lead
dislodgement [9]. Recently, approved quadripolar LV leads have
providedmore options for LV pacing, giving operators more choices
for LV lead positioning with less compromise in lead stability. It
remains however unclear whether these technological advances
translate into better procedural or clinical outcomes for CRT re-
cipients. We therefore sought to investigate differences in the rates
of combined intra-operative and post-operative LV lead related
complications in patients receiving quadripolar versus bipolar LV
leads in real-world clinical practice and examine potential differ-
ences in longer term clinical outcomes.2. Methods
This is a single center, observational study comparing differ-
ences in patient outcomes after CRT based on the type of theElsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
in quadripolar versus bipolar left ventricular leads, Indian Pacing and
008
S. Rijal et al. / Indian Pacing and Electrophysiology Journal xxx (2016) 1e52implanted LV lead LV (Quadripolar vs. Bipolar). The study was
approved by the Institutional Review Board of the University of
Pittsburgh. All patients who had an attempt at CRT deﬁbrillator
(CRT-D) or pacemaker (CRT-P) device implantation at the hospitals
of the University of Pittsburgh Medical Center (UPMC) between
2011 and 2014 were included in this study. Both de novo CRT im-
plantations and upgrades from other devices to CRT were included.
Baseline demographic and clinical variables including pre-
procedural assessment of left ventricular ejection fraction (EF)
were collected. Institutional reports to the National Cardiovascular
Data Registry - ICD registry together with the UPMC electronic
health records (EHR) were used as sources of information.
The index procedure was the de novo or upgrade CRT procedure.
Operative notes were reviewed to identify patients with failed at-
tempts at LV lead placement. EHR were reviewed to capture all
instances of procedural or LV lead related complications. Outcomes
including hospitalization for any reason (device-related complica-
tions, heart failure, and arrhythmia) were abstracted from the EHR.
Phrenic nerve stimulation (PNS) during follow-up visits was also
recorded. Mortality data was obtained from the electronic medical
records, including scanned death certiﬁcates, as well as from the
Social Security Death Index records through October 2015.
The choice of themodel andmanufacturer of CRT devices and LV
leads was left to the discretion of the implanting physician. Quad-
ripolar LV leads included the Food and Drug Administration
approved St. Jude Medical (Sylmar, CA) ‘Quartet’ lead and the
Medtronic (Minneapolis, MN) ‘Attain Performa’ family of leads.
The implantation procedure was performed by electrophysiol-
ogists who were experienced in performing CRT procedures. All
operators had no less than 3 years of experience in implanting LV
leads from different manufacturers. The site of LV pacing was
chosen by the implanting physician based on lead stability, the
absence of PNS, and favorable pacing parameters. Device pro-
gramming was at the discretion of the implanting physician. A
failed attempt at LV lead placement was deﬁned as abandoned LV
lead implantation during the index procedure.
Patients were followed to the primary composite end-point of
LV lead implant failure, dislodgment, or LV pacing deactivation for
PNS in the ﬁrst 12 months after the index procedure. Secondary
outcomes include all-cause hospitalizations, device-related hospi-
talizations, hospitalization for arrhythmia, hospitalization for heart
failure, and all-cause mortality. Hospitalizations were deﬁned as atTable 1
Pre-Implant Characteristics of N ¼ 1441 patients (2011e2014).
Overall Cohort
Number of Patients 1441
Age 72.1 ± 11.6
BMI 29.5 ± 9.9
Diabetes Mellitus 499 (34.6%)
Hypertension 1059 (73.5%)
Prior myocardial Infarction 667 (46.3%)
Prior PCI 355 (24.6%)
Prior CABG 441 (30.6%)
Prior Heart Failure 1266 (87.9%)






Atrial Fibrillation 756 (52.5%)
QRS Width 150 ± 31.4
Creatinine 1.32 ± 0.88
Pre-Implant LVEF 28.4 ± 11.6
CRT Upgrade Procedure 572 (39.7%)
Total Follow Up Time (Days) 609 ± 480
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vation status. Patients were followed by the device clinic at UPMC.
All patients presented to the clinic 2 weeks after the index pro-
cedure for a surgical wound check at the site of device implanta-
tion. Their follow-up thereafter consisted of clinic visits every 6
months or clinic visits once a year with scheduled homemonitoring
downloads every 3 months.
Baseline characteristics were presented as mean ± standard
deviation for continuous variables and as n (%) for categorical var-
iables. Differences between patients receiving quadripolar vs. bi-
polar LV leads were compared using the Student's t-test and chi-
squared tests, respectively. Incidence of time-to-event outcomes
was analyzed using Kaplan-Meier analyses and compared between
quadripolar and bipolar LV lead recipients using the log-rank test.
Statistical analyses were performed using SAS version 9.4 (SAS
Institute, Cary NC).
3. Results
A total of 1441 patients (292 quadripolar and 1149 bipolar) were
implanted with a CRT device between January 2011 to December
2014. They were followed-up for a mean of 609 ± 480 days. Of the
overall cohort, 1220 (85%) patients had at lead 1 year of follow-up.
Table 1 shows the baseline characteristics of the overall cohort and
of the quadripolar vs. bipolar groups. Compared to patients
receiving a bipolar LV lead, patients receiving quadripolar leads
were younger (70.6 ± 11.4 vs. 72.5 ± 11.6, p ¼ 0.01) and had more
Diabetes mellitus (42% versus 33%, p ¼ 0.004). All other baseline
characteristics were comparable between the two groups. Among
the implanted quadripolar LV leads, 224 were from St. Jude Medical
(Sylmar, CA) and 68 fromMedtronic (Minneapolis, MN). Therewere
no differences in LV lead complications or patients outcomes by
lead model or manufacturer.
There were a total of 28 failed attempts at LV lead placement [1
(0.3%) in the quadripolar group vs. 27 (2.3%) in the bipolar group,
p¼ 0.029]. Therewere no instances of switching from a quadripolar
to a bipolar LV lead or vice versa during the index procedure. Over
12 months of follow-up, the composite endpoint of LV lead related
complications occurred signiﬁcantly less in the quadripolar
compared to the bipolar group [8 (2.7%) compared to 78 (6.8%),
p ¼ 0.009]. The individual components of the composite end point
of LV lead related complications and their rates between the twoBipolar Quadripolar P-Value
1149 292
72.5 ± 11.6 70.6 ± 11.4 0.014
29.5 ± 10.6 29.5 ± 6.3 0.932
377 (32.8%) 122 (41.8%) 0.004
840 (73.1%) 219 (75.0%) 0.569
545 (47.4%) 122 (41.8%) 0.076
285 (24.8%) 70 (24.0%) 0.750
357 (31.1%) 84 (28.8%) 0.429
1011 (88.0%) 255 (87.3%) 0.669
387 (33.7%) 105 (36.0%) 0.084
0.178
70 (6.1%) 14 (4.8%)
189 (16.4%) 62 (21.2%)
639 (55.6%) 152 (52.1%)
39 (3.4%) 8 (2.7%)
616 (53.6%) 140 (47.9%) 0.073
150 ± 31.4 150 ± 31.4 0.957
1.30 ± 0.85 1.37 ± 0.99 0.224
28.4 ± 11.6 28.1 ± 11.3 0.652
476 (41.4%) 96 (32.8%) <0.001
698 ± 490 256 ± 189 <0.001
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Table 3
Phrenic nerve stimulation, hospitalizations, and mortality outcomes.
Full Cohort Bipolar Quadripolar P-Value
Number of Patients 1441 1149 292
Phrenic Nerve Stimulation
Within 30 Days 51 (3.5%) 43 (3.7%) 8 (2.7%) 0.481
Within 60 Days 59 (4.1%) 49 (4.3%) 10 (3.4%) 0.620
Within 90 Days 67 (4.6%) 55 (4.8%) 12 (4.1%) 0.755
Within 6 Months 74 (5.1%) 61 (5.3%) 13 (4.5%) 0.656
Within 1 Year 79 (5.5%) 65 (5.7%) 14 (4.8%) 0.666
HF Hospitalization
Within 30 Days 35 (2.4%) 25 (2.2%) 10 (3.4%) 0.206
Within 60 Days 61 (4.2%) 46 (4.0%) 15 (5.1%) 0.415
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signiﬁcant differences in the individual components of the com-
posite endpoint of LV lead related complications, except for lead
placement failures, the combined composite endpoint was reached
signiﬁcantly less (Hazard Ratio 0.22, 95% Conﬁdence Interval
0.08e0.60, p ¼ 0.001) in quadripolar vs. bipolar LV lead recipients
(Fig. 1).
As shown is Table 3, there were no statistically signiﬁcant dif-
ferences in the secondary endpoints of the study. The rates of
mortality and hospitalizations (Fig. 2) for any cause were compa-
rable between recipients of quadripolar and bipolar LV leads. As
shown in Table 3, therewere a total of 79 patients who experienced
PNS in the ﬁrst year after implantation: 65 (5.7%) with bipolar leads
and 14 (4.8%) with quadripolar leads. In these patients, 59 of 65
(91%) in the bipolar lead group and 12 of 14 (86%) in the quadripolar
lead group had resolution of PNS with adjustment of the pacing
settings.
4. Discussion
Our ﬁndings demonstrate that the use of quadripolar LV leadsTable 2
Lead placement failure, lead dislodgement, and lead deactivations.
Overall Cohort Bipolar Quadripolar P-Value
Number of Patients 1441 1149 292
Lead Placement Failure 28 (1.9%) 27 (2.3%) 1 (0.3%) 0.029
Lead Dislodgement
Within 30 Days 24 (1.7%) 23 (2.0%) 1 (0.3%) 0.067
Within 60 Days 27 (1.9%) 26 (2.3%) 1 (0.3%) 0.028
Within 90 Days 30 (2.1%) 29 (2.5%) 1 (0.3%) 0.019
Within 6 Months 37 (2.6%) 33 (2.9%) 4 (1.4%) 0.211
Within 1 Year 41 (2.8%) 35 (3.0%) 6 (2.1%) 0.435
Lead Deactivation
Within 30 Days 9 (0.6%) 9 (0.8%) 0 (0.0%) 0.218
Within 60 Days 10 (0.7%) 10 (0.9%) 0 (0.0%) 0.227
Within 90 Days 12 (0.8%) 12 (1.0%) 0 (0.0%) 0.140
Within 6 Months 15 (1.0%) 14 (1.2%) 1 (0.3%) 0.329
Within 1 Year 17 (1.2%) 16 (1.4%) 1 (0.3%) 0.221
Fig. 1. Incidence of the composite endpoint of failed lead placement, lead dislodgement, or
leads in CRT recipients.
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Electrophysiology Journal (2016), http://dx.doi.org/10.1016/j.ipej.2016.10.reduces the combined intra-operative and post-operative LV lead
related complications over a 12 months follow-up period. Judging
by the early curve separation demonstrated in Fig. 1, the superior
performance of the quadripolar lead seems to be mainly driven by
less intra-operative failures of placement or early post-procedural
LV lead dislodgement or deactivation for PNS. The implications of
our ﬁndings are that quadripolar LV leads, by virtue of thelead being turned off over one year post-implantation for quadripolar and bipolar LV
Within 90 Days 82 (5.7%) 64 (5.6%) 18 (6.2%) 0.672
Within 6 Months 124 (8.6%) 98 (8.5%) 26 (8.9%) 0.815
Within 1 Year 176 (12.2%) 145 (12.6%) 31 (10.6%) 0.423
Arrhythmia Hospitalization
Within 30 Days 18 (1.2%) 13 (1.1%) 5 (1.7%) 0.386
Within 60 Days 35 (2.4%) 28 (2.4%) 7 (2.4%) 1.000
Within 90 Days 46 (3.2%) 39 (3.4%) 7 (2.4%) 0.459
Within 6 Months 66 (4.6%) 58 (5.0%) 8 (2.7%) 0.115
Within 1 Year 99 (6.9%) 84 (7.3%) 15 (5.1%) 0.242
Any Hospitalization
Within 30 Days 140 (9.7%) 108 (9.4%) 32 (11.0%) 0.438
Within 60 Days 241 (16.7%) 191 (16.6%) 50 (17.1%) 0.860
Within 90 Days 296 (20.5%) 243 (21.1%) 53 (18.2%) 0.291
Within 6 Months 397 (27.6%) 325 (28.3%) 72 (24.7%) 0.240
Within 1 Year 521 (36.2%) 429 (37.3%) 92 (31.5%) 0.065
Mortality
Within 30 Days 30 (2.1%) 26 (2.3%) 4 (1.4%) 0.490
Within 60 Days 42 (2.9%) 36 (3.1%) 6 (2.1%) 0.435
Within 90 Days 52 (3.6%) 46 (4.0%) 6 (2.1%) 0.157
Within 6 Months 99 (6.9%) 85 (7.4%) 14 (4.8%) 0.121
Within 1 Year 147 (10.2%) 126 (11.0%) 21 (7.2%) 0.065
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Fig. 2. Incidence of all-cause hospitalizations (upper panel) and all-cause mortality (lower panel) over one year post-implantation for quadripolar and bipolar LV leads in CRT
recipients.
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success rates of LV lead placement in more stable positions, thus
translating into fewer lead dislodgements and lead deactivations in
follow-up.
Our ﬁndings are consistent with some but not all ﬁndings from
other comparable smaller [10,11] and larger [12,13] studies. The
randomized MORE-CRT trial [12,13] showed an increased proce-
dural success and reduced intra- and post-operative complications
with the use of quadripolar LV leads. Contrary to the results of
previous work however, our study does not show a difference in
mortality or rates of hospitalizations for heart failure or PNS in
recipients of quadripolar versus bipolar LV leads [11,14,15]. It is
worth noting however that our study was based exclusively on our
institutional records, independent of data sponsored by industry. InPlease cite this article in press as: Rijal S, et al., Lead related complications
Electrophysiology Journal (2016), http://dx.doi.org/10.1016/j.ipej.2016.10.addition, our study is the ﬁrst to look at the combined performance
of quadripolar leads from two manufacturers as all prior studies
focused on one lead model from a single manufacturer [13,16].
Lastly, our study has included LV leads implanted with CRT-D and
CRT-P devices, unlike all other similar studies that focused exclu-
sively on CRT-D recipients.
Our current study has limitations. First, it is retrospective and
therefore may inherently have selection and information bias. The
type of LV lead implanted was dependent on operator choice as
well as the availability of quadripolar leads in the United States,
which started 2011. There is a possibility of selection bias but we
have included in our analysis all patients whowere implanted with
bipolar or quadripolar LV leads over the study period, without any
exclusion to minimize bias. Moreover, the baseline clinicalin quadripolar versus bipolar left ventricular leads, Indian Pacing and
008
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similar. Another limitation is that our study was conducted at a
single hospital system, so our results may not be reproducible at
other institutions or in other clinical settings. However, it is worth
noting that CRT implantation and subsequent management of LV
lead-related complications are typically performed at tertiary
centers with similar levels of expertise to those available at our
institution. In addition, although all operative notes were reviewed
and nonemention switching LV lead type or shape during the index
procedure due to difﬁcult anatomy of other procedural consider-
ations, we cannot exclude that this may have happened but not
dictated in the operative note. Lastly, although quadripolar leads
were implanted in 292 patients in our study, no patient received LV
multipoint pacing.
5. Conclusion
In the real world setting, quadripolar LV leads have signiﬁcantly
lower rates of implantation failure and post-operative lead
dislodgement or deactivation. These results which have important
clinical implications to CRT recipients need to be validated in larger
multicenter data.
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